Digestives & Intestinal Remedies - Portugal

Portugal

Highlights

In Portugal, the revenue generated in the Digestives & Intestinal Remedies market market is estimated to be US$88.99m in 2024.
This market is projected to experience an annual growth rate of 1.86% (CAGR 2024-2029).
When compared globally, China leads the way with a revenue of US$4.41bn in 2024.
In terms of per person revenues, in Portugal generates US$8.70 in 2024.
Portugal has seen a rising demand for probiotic digestive remedies, driven by increasing awareness of gut health.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in Portugal is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Portugal are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This shift in preference can be attributed to growing awareness about the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for natural digestive remedies such as herbal teas, probiotics, and dietary supplements.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Portugal is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and promote a healthy digestive system. Probiotic supplements and fermented foods like yogurt and kefir are gaining traction among consumers who are looking for ways to improve their gut health.Another trend in the market is the increasing availability of over-the-counter digestive remedies. This trend can be attributed to the growing self-care trend and the desire for quick and convenient solutions to digestive issues. Pharmacies and supermarkets in Portugal are expanding their range of over-the-counter digestive remedies to cater to this demand.

Local special circumstances: Portugal has a high prevalence of gastrointestinal disorders, such as irritable bowel syndrome (IBS) and acid reflux. These conditions affect a significant portion of the population and contribute to the demand for digestive and intestinal remedies. The local healthcare system in Portugal also plays a role in driving the demand for these products, as patients often seek over-the-counter solutions before consulting a healthcare professional.

Underlying macroeconomic factors: The growing Digestives & Intestinal Remedies market in Portugal can also be attributed to favorable macroeconomic factors. Portugal has experienced stable economic growth in recent years, which has led to increased disposable income among consumers. This allows them to spend more on healthcare products, including digestive remedies. Additionally, the aging population in Portugal is driving the demand for digestive and intestinal remedies, as older individuals are more prone to digestive issues and seek solutions to manage their symptoms.In conclusion, the Digestives & Intestinal Remedies market in Portugal is witnessing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the popularity of probiotics, the availability of over-the-counter solutions, the high prevalence of gastrointestinal disorders, and favorable macroeconomic conditions are all contributing to the development of this market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.